Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population.

Autor: Avirmed S; Division of Urology, Department of Surgery, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia., Wang BS; Department of Biomedical Imaging and Radiological Sciences, School of Biomedical Engineering, National Yang-Ming University, Taipei 112, Taiwan., Selenge B; Division of Urology, Department of Surgery, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia., Sanjaajamts A; Division of Urology, Department of Surgery, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia., Ganbat B; Division of Urology, Department of Surgery, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia., Erdenebileg U; Division of Urology, Department of Surgery, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia., Purevsuren M; Division of Urology, Department of Surgery, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.; Department of Urology, First Central Hospital of Mongolia, Ulaanbaatar 210648, Mongolia., Jigjidsuren S; Department of Clinical Laboratory, First Central Hospital of Mongolia, Ulaanbaatar 210648, Mongolia., Batmunkh M; Science Technology Center, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia., Lee YJ; Department of Biomedical Imaging and Radiological Sciences, School of Biomedical Engineering, National Yang-Ming University, Taipei 112, Taiwan.; Biophotonics and Molecular Imaging Research Center (BMIRC), National Yang-Ming University, Taipei 112, Taiwan.
Jazyk: angličtina
Zdroj: Molecular and clinical oncology [Mol Clin Oncol] 2017 Sep; Vol. 7 (3), pp. 412-420. Date of Electronic Publication: 2017 Jul 13.
DOI: 10.3892/mco.2017.1317
Abstrakt: The current study aims to investigate whether MDM2-SNP309 and p53R72P polymorphisms were associated with the risk of bladder cancer in Mongolian populations. These polymorphisms were evaluated in 79 controls and 63 bladder cancer cases using a PCR-restriction fragment length polymorphism assay, followed by analysis using multivariate logistic regression model and the Kaplan-Meier model to determine the odds ratio (OR) and age at onset of bladder cancer, respectively. The results revealed that the homozygous (G/G) genotype of MDM2-SNP309 increased the risk of bladder cancer compared to the wild-type (T/T) genotype [OR=1.629; 95% confidence interval (CI)=0.622-4.266] among Mongolians. On the other hand, the homozygous (P/P) genotype of p53R72P tended to protect the population from bladder cancer compared with the wild-type (R/R) genotype (OR=0.445; 95% CI=0.1727-2.147). It also showed that G/G genotype of MDM2-SNP309 increased the risk of bladder cancer when combined with the R/R genotype of p53R72P (OR=3.355; 95% CI=0.3914-28.766). Stratification by smoking and history of chronic urinary tract diseases tended towards increasing the risk association of the G/G (OR=2.3704; 95% CI=0.4308-3.044) and T/G genotypes (OR=5; 95% CI=0.8442-30.4088) of MDM2-SNP309 with bladder cancer, respectively. The protective role of P/P of p53R72P remained following stratification. MDM2-SNP309 and p53R72P were not involved in early age onset of bladder cancer in Mongolian patients. Taken together, MDM2-SNP309 and p53R72P had no significant association with bladder cancer in Mongolian patients. The two SNPs were also not able to predict early age at onset of bladder cancer.
Databáze: MEDLINE
Externí odkaz: